Goldline Pharmac

Market Cap: N/A
Industry: Pharmaceuticals & Biotechnology
ISIN: INE1CLW01015
NSEID:
BSEID: 544759
View on BSE

INR

53.94

-2.83 (-4.99%)

BSENSE

May 20

BSE+NSE Vol: 21000

Access older stock analysis version

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Which are the latest news on Goldline Pharmac?

20-May-2026

No latest news for Goldline Pharmac found.

Compare Goldline Pharmac with Similar Stocks

Phaarmasia Shelter Pharma Onyx Biotec

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

INR 52 Cr ()

P/E

18.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.00

Return on Equity

0.00%

Price to Book

0.00

Revenue and Profits:

Net Sales:

(Quarterly Results - )

Net Profit:

Total Returns

Total Returns (Price + Dividend)

Company does not have enough history

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

No Recent News for the Company

Announcements

Listing of Equity Shares of Goldline Pharmaceutical Ltd

19-May-2026 | Source : BSE

Trading Members of the Exchange are hereby informed that effective from May 19 2026 the Equity Shares of Goldline Pharmaceutical Ltd (Scrip Code: 544759) are listed and admitted to dealings on the Exchange in the list of MT Group Securities. For further details please refer to the notice no. 20260518- dated May 18 2026.

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

2.91

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

26.42%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

12.97%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

5.00

EV to EBIT

10.62

EV to EBITDA

10.17

EV to Capital Employed

3.31

EV to Sales

2.12

PEG Ratio

Dividend Yield

ROCE (Latest)

31.13%

ROE (Latest)

27.33%

Technicals key factors

Indicator

Weekly

Monthly

Technical indicator has not been calculated since the stock has been active for a short period

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Goldline Pharmac"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Goldline Pharmac"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Goldline Pharmac"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "alert": "No Annual Results declared by Goldline Pharmac"
  }
]

Company CV

About Goldline Pharmaceutical Ltd

Goldline Pharmaceutical Ltd

Pharmaceuticals & Biotechnology

Goldline Pharmaceutical Limited was originally incorporated on August 2, 2004, as a private limited Company in the name of `Goldline Pharmaceutical Private Limited' with the Registrar of Companies, Mumbai. Subsequently, Company was converted into a public limited Company and the name of Company was changed to `Goldline Pharmaceutical Limited' w.e.f. September 23, 2013. Company is engaged in the business of marketing pharmaceutical products under the Goldline brand.

Company Coordinates

No Company Details Available